
Veru Inc. | A Biopharmaceutical Company
Feb 26, 2026 · Veru is focused on the development of enobosarm, a novel, oral, selective androgen receptor modulator (SARM) to address one of the most significant adverse effects, the loss of …
Veru Inc. (VERU) Stock Price, News, Quote & History - Yahoo Finance
Find the latest Veru Inc. (VERU) stock quote, history, news and other vital information to help you with your stock trading and investing.
Veru Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch
3 days ago · VERU | Complete Veru Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
VERU - Veru Inc Stock Price Quote - NASDAQ | Morningstar
6 days ago · See the latest Veru stock price NASDAQ: VERU stock rating, related news, valuation, dividends and more to help you make your investing decisions.
Veru Inc. (VERU) Stock Price & Overview
5 days ago · A detailed overview of Veru Inc. (VERU) stock, including real-time price, chart, key statistics, news, and more.
Veru Inc.
Feb 4, 2026 · Veru is a biopharmaceutical company focused on developing novel medicines for high-quality weight loss, breast cancer, and viral related ARDS.
VERU - VERU INC | Stock Quotes from Fidelity Investments
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome …
Veru Inc (VERU) Stock Price & News - Google Finance
Get the latest Veru Inc (VERU) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Veru Inc. (VERU) Stock Price, Quote, News & Analysis | Seeking Alpha
A high-level overview of Veru Inc. (VERU) stock. View (VERU) real-time stock price, chart, news, analysis, analyst reviews and more.
Veru (VERU) AI Stock Analysis | Smart Price Targets & Insights ...
Feb 12, 2026 · Get a real-time Veru (VERU) stock analysis report, powered by AI. See VERU business overview, financial statement overview and technical analysis